795
Participants
Start Date
April 30, 2004
Primary Completion Date
August 31, 2006
Study Completion Date
September 30, 2007
17 alpha-hydroxyprogesterone caproate (17P)
Study coded medication is 250 mg of 17P as a 1 ml intramuscular injection (or 1 ml of placebo inert oil). Patients are seen weekly to administer the study drug through 34 weeks 6 days gestation or delivery, whichever occurs first.
Columbia University, New York
University of Pittsburgh Magee Womens Hospital, Pittsburgh
Dexel University, Philadelphia
Wake Forest University School of Medicine, Winston-Salem
University of North Carolina - Chapel Hill, Chapel Hill
University of Alabama - Birmingham, Birmingham
Ohio State University, Columbus
Case Western University, Cleveland
Wayne State University, Detroit
Northwestern University, Chicago
University of Texas - Southwest, Dallas
University of Texas - Houston, Houston
University of Utah Medical Center, Salt Lake City
Brown University, Providence
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
The George Washington University Biostatistics Center
OTHER